Mitsubishi UFJ Asset Management
LBRX

Mitsubishi UFJ Asset Management’s LB Pharmaceuticals LBRX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Buy
+1,400
New +$41.1K ﹤0.01% 1143

Other funds holding LBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mitsubishi UFJ Asset Management's LBRX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management opened a new position in LB Pharmaceuticals (LBRX) in Q2 2026: 1,400 shares worth $45.4K. The stake represents ﹤0.01% of the portfolio and ranks #1143 among its holdings.

29 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 1,400 shares of LB Pharmaceuticals worth $45.4K as of Q2 2026.
  • LB Pharmaceuticals was a new Mitsubishi UFJ Asset Management position in Q2 2026.
  • LB Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1143 holding.
  • 29 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.